# An International Trial to Evaluate the Efficacy and Safety of SABER®-Bupivacaine for Postoperative Pain Control in Patients Undergoing Hysterectomy

> **NCT00993226** · PHASE2 · COMPLETED · sponsor: **Durect** · enrollment: 115 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** SABER-Bupivacaine Treatment 1a
- **DRUG:** Placebo SABER-Bupivacaine Treatment 1b
- **DRUG:** Bupivacaine HCl Treatment 1c
- **DRUG:** SABER-Bupivacaine Treatment 2a
- **DRUG:** Placebo SABER-Bupivacaine Treatment 2b
- **DRUG:** Bupivacaine HCl Treatment 2c

## Key facts

- **NCT ID:** NCT00993226
- **Lead sponsor:** Durect
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2009-12
- **Final completion:** 2010-07
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2021-06-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00993226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00993226, "An International Trial to Evaluate the Efficacy and Safety of SABER®-Bupivacaine for Postoperative Pain Control in Patients Undergoing Hysterectomy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00993226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*